ANTARES PHARMA INC (ATRS)
Institutional ownership reported to the SEC as of Q3 2022, across 16 quarters.
1
Reporting holders
$12.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $12.0K | 4,369 | 0.00% | 13q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2022 | 1 | $12.0K | 4,369 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 1 | $12.0K | 4,369 | 0 | 0 | 1 | 0.0% |
| Q1 2022 | 175 | $375.7M | 91,535,702 | 23 | 47 | 56 | 0.3% |
| Q4 2021 | 163 | $307.9M | 86,041,177 | 14 | 58 | 54 | 0.3% |
| Q3 2021 | 169 | $301.0M | 82,411,552 | 18 | 69 | 40 | 0.3% |
| Q2 2021 | 174 | $360.1M | 82,142,726 | 24 | 48 | 42 | 0.5% |
| Q1 2021 | 171 | $341.8M | 82,527,518 | 21 | 53 | 48 | 0.7% |
| Q4 2020 | 175 | $295.0M | 73,271,937 | 17 | 46 | 52 | 0.9% |
| Q3 2020 | 165 | $182.3M | 66,923,127 | 17 | 39 | 56 | 0.7% |
| Q2 2020 | 161 | $198.0M | 71,837,630 | 19 | 56 | 45 | 0.4% |
| Q1 2020 | 155 | $158.1M | 66,603,262 | 20 | 48 | 40 | 0.6% |
| Q4 2019 | 160 | $343.1M | 72,336,992 | 33 | 53 | 38 | 1.0% |
| Q3 2019 | 134 | $206.9M | 60,870,942 | 21 | 38 | 33 | 1.6% |
| Q2 2019 | 128 | $213.2M | 62,781,716 | 17 | 44 | 33 | 3.2% |
| Q1 2019 | 130 | $216.1M | 69,993,456 | 22 | 36 | 34 | 1.9% |
| Q4 2018 | 120 | $188.7M | 68,612,188 | 2 | 1 | 4 | 1.1% |